TNF-α downregulates the leukotriene C4 synthase gene in mononuclear phagocytes

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 292, Issue 1, 2007, Pages

  Serio, Kenneth J ^a,c   Luo, Colin ^a   Luo, Linda ^a   Mao, Jenny T ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Inflammation; Lipopolysaccharides; Lipoxygenase; Toll like receptor

Indexed keywords

CALCIUM IONOPHORE; CYCLOOXYGENASE 2; DACTINOMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKOTRIENE C4 SYNTHASE; NITRIC OXIDE SYNTHASE; PEPTIDOLEUKOTRIENE; PROTEIN P50; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME DEGRADATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MACROPHAGE; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CALCIMYCIN; CELL LINE; DOWN-REGULATION; GLUTATHIONE TRANSFERASE; HUMANS; IONOPHORES; LEUKOTRIENE C4; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MONOCYTES; NF-KAPPA B; PHAGOCYTES; RECOMBINANT PROTEINS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846222420     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00023.2006     Document Type: Article

References (35)

1. Bailie MB, Standiford TJ, Laichalk LL, Coffey MJ, Strieter R, Peters-Golden M. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol 157: 5221-5224, 1996.
2. Baumann MA, Paul CC. The Aml14 and Aml14.3D10 cell lines: a long-overdue model for the study of eosinophils and more. Stem Cells 16: 16-24, 1998.
3. Benjamim CF, Canetti C, Cunha FQ, Kunkel SL, Peters-Golden M. Opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis. J Immunol 174: 1616-1620, 2005.
4. 4 synthase gene and assignment to chromosome 5q35. Mol Med 2: 637-646, 1996.
5. Bigby TD, Meslier N. Transcellular metabolism between monocytes and platelets. J Immunol 143: 1948-1954, 1989.
6. Coffey MJ, Phare SM, Peters-Golden M. Prolonged exposure to lipopolysaccharide inhibits macrophage 5-lipoxygenase metabolism via induction of nitric oxide synthesis. J Immunol 165: 3592-3598, 2000.
7. Dempsey PW, Doyle SE, He JQ, Cheng G. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 14: 193-209, 2003.
8. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18: 6867-6874, 1999.
9. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 323: 645-655, 1990.
10. Li W, Lin J, Adams GL, Juhn SK. Expression of inducible nitric oxide synthase (iNOS) in middle ear epithelial cells by IL-1beta and TNF-alpha. Int J Pediatr Otorhinolaryngol 55: 91-98, 2000.
11. Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med 174: 1517-1526, 1991.
12. Makker HK, Lau LC, Thomson HW, Binks SM, Holgate ST. The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma. Am Rev Respir Dis 147: 1413-1418, 1993.
13. 4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide. Clin Cancer Res 10: 6872-6878, 2004.
14. Martin-Orozco E, Kobayashi H, Van Uden J, Nguyen MD, Kornbluth RS, Raz E. Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences. Int Immunol 11: 1111-1118, 1999.
15. Matricardi PM, Bonini S. High microbial turnover rate preventing atopy: a solution to inconsistencies impinging on the hygiene hypothesis? Clin Exp Allergy 30: 1506-1510, 2000.
16. 6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem 37: 3886-3888, 1994.
17. Morlion BJ, Torwestern E, Kuhn K, Puchstein C, Furst P. Cysteinyl-leukotriene generation as a biomarker for survival in the critically ill. Crit Care Med 28: 3655-3658, 2000.
18. Namovic MT, Walsh RE, Goodfellow C, Harris RR, Carter GW, Bell RL. Pharmacological modulation of eosinophil influx into the lungs of Brown Norway rats. Eur J Pharmacol 315: 81-88, 1996.
19. 4 synthase. Organization, nucleotide sequence, and chromosomal localization to 5q35. J Biol Chem 271: 11356-11361, 1996.
20. 4 synthase and preparation of a polyclonal antibody. Am J Respir Crit Care Med 152: 283-289, 1995.
21. Peters-Golden M, Canetti C, Mancuso P, Coffey MJ. Leukotrienes: underappreciated mediators of innate immune responses. J Immunol 174: 589-594, 2005.
22. Reddy KV, Serio KJ, Hodulik CR, Bigby TD. 5-Lipoxygenase- activating protein gene expression. Key role of CCAAT/enhancer-binding proteins (C/EBP) in constitutive and tumor necrosis factor (TNF) alpha-induced expression in THP-1 cells. J Biol Chem 278: 13810-13818, 2003.
23. 4 synthase expression in the monocyte-like cell line, THP-1. J Immunol 162: 1102-1107, 1999.
24. Ring WL, Riddick CA, Baker JR, Munafo DA, Bigby TD. Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte macrophage colony-stimulating factor and interleukin-3. Clin Res 97: 1293-1301, 1996.
25. 4 synthase during lipopolysaccharide-induced pyresis. Cell Mol Life Sci 62: 87-94, 2005.
26. 4 synthase gene expression in the monocyte-like cell line, THP-1. Am J Respir Cell Mol Biol 23: 234-240, 2000.
27. 4 synthase gene expression in a cell-specific manner in the monocyte-like cell line, THP-1. Chest 123: 426S, 2003.
28. 4 synthase gene in the monocyte-like cell line, THP-1. J Immunol 170: 2121-2128, 2003.
29. Serio KJ, Reddy KV, Bigby TD. Lipopolysaccharide induces 5-lipoxygenase activating protein gene expression in THP-1 cells via a NF-κB and C/EBP-mediated mechanism. Am J Physiol Cell Physiol 288: C1125-C1133, 2005.
30. Takada Y, Aggarwal BB. Genetic deletion of the tumor necrosis factor receptor p60 or p80 sensitizes macrophages to lipopolysaccharide-induced nuclear factor-kappa B, mitogen-activated protein kinases, and apoptosis. J Biol Chem 278: 23390-23397, 2003.
31. Ulevitch RJ, Tobias PS. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 11: 19-22, 1999.
32. Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 273: 3285-3290, 1998.
33. Yamamoto K, Arakawa T, Taketani Y, Takahashi Y, Hayashi Y, Ueda N, Yamamoto S, Kumegawa M. TNF alpha-dependent induction of cyclooxygenase-2 mediated by NF kappa B and NF-IL6. Adv Exp Med Biol 407: 185-189, 1997.
34. Yao J, Mackman N, Edgington TS, Fan ST. Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells. J Biol Chem 272: 17795-17801, 1997.
35. 4 synthase involves a Kruppel-like transcription factor and Sp1. J Biol Chem 275: 8903-8910, 2000.